Dr. Eddie Reed, an award-winning physician and internationally recognized cancer researcher, has been appointed clinical director of the National Institute on Minority Health and Health Disparities.
“Dr. Reed is a perfect fit as we continue to build our clinical research program into a source of novel concepts, guidance and evidence in health disparities research,” said NIMHD director Dr. John Ruffin. “He is a leading oncologist and scientist who is committed to finding solutions to health disparities.”
Reed will oversee a combination of studies including outpatient, inpatient, epidemiological, clinical and laboratory-based work. “I am delighted to be joining the team at NIMHD, where I will focus on translating what we learn in the lab into advancements that improve and save lives,” said Reed. He will lead the NIMHD effort in enhancing the recruitment and retention of minorities and other underserved populations into clinical trials.
He comes from the University of South Alabama, where he was the Abraham Mitchell distinguished investigator at Mitchell Cancer Institute. He has also carried out clinical research and served as chief of the Clinical Pharmacology Branch at NCI and directed the Mary Babb Randolph Cancer Center at West Virginia University. At the Centers for Disease Control and Prevention, he was director of the Division of Cancer Prevention and Control.
Reed is board-certified in internal medicine and has won many awards for his work in oncology including being listed as a top doctor by U.S. News and World Report and winning two Public Health Service Commendation Medals for his research on the cancer-fighting agent paclitaxel (Taxol). He has conducted more than four dozen phase I or phase II clinical trials on anti-cancer agents. Much of his research has focused on DNA damage and repair mechanisms in cancer cells. He has also worked on local, state and national efforts for cancer control and prevention.
He earned his undergraduate degree from Philander Smith College in Little Rock, Ark., and his medical degree from Yale University School of Medicine. He completed his internship and residency at Stanford University and a fellowship at NCI. He served on the Institute of Medicine’s National Cancer Policy Forum from 2005 to 2008. He is also a past member of the National Advisory Council on Minority Health and Health Disparities.